Lexicon
Alzheimer's Disease
Also known as Alzheimer's
Definition
Alzheimer's disease is a chronic neurodegenerative disease characterized by progressive cognitive decline and distinct neuropathological features, with no definitive cure currently available. [1] It is the most common type of dementia and typically manifests through a progressive loss of episodic memory and cognitive function, often accompanied by behavioral disorders such as apathy, aggressiveness, and depression. [2] It is a chronic illness with long preclinical and prodromal phases and an average clinical duration of 8 to 10 years, and most patients have the sporadic, late-onset form. [3]
How it works
The presence of extracellular plaques of insoluble beta-amyloid peptide and neurofibrillary tangles containing hyperphosphorylated tau protein in the neuronal cytoplasm is a remarkable pathophysiological feature in patients' brains. [2] The amyloid hypothesis holds that the disease is caused by the accumulation of amyloid beta protein in the brain, leading to neuronal toxicity, and the sporadic form is considered a consequence of the failure to clear the amyloid-beta peptide from the brain. [4] [3] Accumulating evidence highlights mitochondrial dysfunction, together with oxidative stress and disturbances in energy metabolism, as a central factor in disease pathogenesis. [1] The APOE ε4 allele remains the strongest genetic risk factor for sporadic Alzheimer's disease, with apoE4 seeding amyloid-β aggregation and impairing its clearance in the brain [5].
Diagnosis & epidemiology
Alzheimer's disease is the leading cause of dementia, accounting for 50 to 70% of cases, and its global prevalence is expected to continue to rise as populations age. [6] The disease has an estimated prevalence of 10 to 30% in the population older than 65 years of age with an incidence of 1 to 3%. [3] Accumulation of amyloid-beta can now be detected in preclinical and prodromal phases using cerebrospinal fluid biomarkers and PET imaging. [3]
Why it matters
Approximately 70% of the risk of developing Alzheimer's disease can be attributed to genetics, but acquired factors such as cerebrovascular disease, diabetes, hypertension, obesity, and dyslipidemia increase the risk. [2] Around a third of dementia cases are attributable to modifiable risk factors such as physical inactivity, smoking, and hypertension, and exercise has emerged as a key intervention for positively influencing cognition. [7] Several approved drugs ameliorate some symptoms of the disease, but no current interventions can modify the underlying disease mechanisms. [3]
Connected concepts
Community knowledge
## Blood Biomarker Panels For Early Detection
The longevitydocs community's collective insight and shared knowledge on this concept — across text, video, audio and images from members and faculty, reserved for members.
Learn about our Membership planReferences
- 1.D'Alessandro MCB, Kanaan S, Geller M, Praticò D, Daher JPL. Mitochondrial dysfunction in Alzheimer's disease. Ageing Res Rev · 2025
- 2.Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer's disease: risk factors and potentially protective measures. J Biomed Sci · 2019
- 3.Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer's disease. Nat Rev Dis Primers · 2015
- 4.Ma C, Hong F, Yang S. Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions. Molecules · 2022
- 5.Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol · 2021
- 6.Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT.
Community discussion
Clinical pearls and discussion posted by community members on this concept — signed contributions, reserved for members.
Learn about our Membership plan